Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Charles River Laboratories 1Q11 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Charles River Laboratories 1Q11

Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories

1Q Revenues: $285.8 million (-2%)

1Q Earnings: $35.4 million (+80%)

Comments: Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million. Research Models and Services (RMS) segment sales were up 1% to $173.4 million. Earnings include an $11.1 million corporate tax benefit in continuing operations related to the disposition of the Phase I clinical business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters